1,285
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

The pro-migration and anti-apoptosis effects of HMGA2 in HUVECs stimulated by hypoxia

, , , , , & show all
Pages 3534-3545 | Received 05 Jun 2020, Accepted 09 Nov 2020, Published online: 14 Dec 2020

References

  • Cassavaugh J, Lounsbury KM. Hypoxia-mediated biological control. J Cell Biochem. 2011;112(3):735–744.
  • Cheng F, Lan J, Xia W, et al. Folic acid attenuates vascular endothelial cell injury caused by hypoxia via the inhibition of ERK1/2/NOX4/ROS pathway. Cell Biochem Biophys. 2016;74(2):205–211.
  • Tabata Y, Yoshino D, Funamoto K, et al. Migration of vascular endothelial cells in monolayers under hypoxic exposure. Integr Biol (Camb). 2019;11(1):26–35.
  • Hammond SM. Sharpless NE HMGA2, microRNAs, and stem cell aging. Cell. 2008;135(6):1013–1016.
  • Oliveira-Mateos C, Sanchez-Castillo A, Soler M, et al. The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition. Nat Commun. 2019;10(1):3979.
  • Huang W, Li J, Guo X, et al. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2. Biomed Pharmacother. 2016;81:431–438.
  • Li Y, Zhao Z, Xu C, et al. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Cancer Lett. 2014;355(1):130–140.
  • Monzen K, Ito Y, Naito AT, et al. A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat Cell Biol. 2008;10(5):567–574.
  • Zhu J, Lin X, Yan C, et al. microRNA-98 protects sepsis mice from cardiac dysfunction, liver and lung injury by negatively regulating HMGA2 through inhibiting NF-kappaB signaling pathway. Cell Cycle. 2019;18(16):1948–1964.
  • Wong LL, Saw EL, Lim JY, et al. MicroRNA Let-7d-3p contributes to cardiac protection via targeting HMGA2. Int J Mol Sci. 2019;20(7). DOI:10.3390/ijms20071522
  • Wu QQ, Xiao Y, Liu C, et al. The protective effect of high mobility group protein HMGA2 in pressure overload-induced cardiac remodeling. J Mol Cell Cardiol. 2019;128:160–178.
  • Wu QQ, Xiao Y, Duan MX, et al. Aucubin protects against pressure overload-induced cardiac remodelling via the beta3 -adrenoceptor-neuronal NOS cascades. Br J Pharmacol. 2018;175(9):1548–1566.
  • Halder A, Yadav K, Aggarwal A, et al. Activation of TNFR1 and TLR4 following oxygen glucose deprivation promotes mitochondrial fission in C6 astroglial cells. Cell Signal. 2020;75:109714.
  • Katusic ZS. Austin SA Endothelial nitric oxide: protector of a healthy mind. Eur Heart J. 2014;35(14):888–894.
  • Jaitovich A, Jourd’heuil D. A brief overview of nitric oxide and reactive oxygen species signaling in hypoxia-induced pulmonary hypertension. Adv Exp Med Biol. 2017;967:71–81.
  • Balamurugan K. HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer. 2016;138(5):1058–1066.
  • Luo W, Wang Y. Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-alpha protein stability and activity. Cell Mol Life Sci. 2018;75(6):1043–1056.
  • Ahn GO, Seita J, Hong BJ, et al. Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8. Proc Natl Acad Sci U S A. 2014;111(7):2698–2703.
  • Zhang PC, Liu X, Li MM, et al. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1alpha/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo. Biochem Pharmacol. 2020;172:113771.
  • Du Y, Ge Y, Xu Z, et al. Hypoxia-Inducible Factor 1 alpha (HIF-1alpha)/Vascular Endothelial Growth Factor (VEGF) pathway participates in angiogenesis of myocardial infarction in muscone-treated mice: preliminary study. Med Sci Monit. 2018;24:8870–8877.
  • Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002;2(10):795–803.
  • Amini A, Masoumi Moghaddam S, Morris DL, et al. The critical role of vascular endothelial growth factor in tumor angiogenesis. Curr Cancer Drug Targets. 2012;12(1):23–43.
  • Izzedine H, Ederhy S, Goldwasser F, et al. Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol. 2009;20(5):807–815.
  • Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 2010;60(4):222–243.
  • Bos R, Zhong H, Hanrahan CF, et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst. 2001;93(4):309–314.
  • Yang L, Guan H, He J, et al. VEGF increases the proliferative capacity and eNOS/NO levels of endothelial progenitor cells through the calcineurin/NFAT signalling pathway. Cell Biol Int. 2012;36(1):21–27.
  • Kim JH, Lee KS, Lee DK, et al. Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3. Antioxid Redox Signal. 2014;21(18):2469–2482.
  • Park JS, Hong GR, Baek SW, et al. Expression and regulation of endothelial nitric oxide synthase by vascular endothelial growth factor in ECV 304 cells. J Korean Med Sci. 2002;17(2):161–167.
  • Jujo K, Ii M, Sekiguchi H, et al. CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism. Circulation. 2013;127(1):63–73.
  • Kolluru GK, Sinha S, Majumder S, et al. Shear stress promotes nitric oxide production in endothelial cells by sub-cellular delocalization of eNOS: A basis for shear stress mediated angiogenesis. Nitric Oxide. 2010;22(4):304–315.
  • Xiao G, Wang X, Yu Y. CXCR4/Let-7a axis regulates metastasis and chemoresistance of pancreatic cancer cells through targeting HMGA2. Cell Physiol Biochem. 2017;43(2):840–851.
  • Wu J, Zhang S, Shan J, et al. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer. Cancer Lett. 2016;376(2):284–292.
  • Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999;96(6):857–868.
  • Matsui T, Li L, Del Monte F, et al. Adenoviral gene transfer of activated phosphatidylinositol 3ʹ-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation. 1999;100(23):2373–2379.
  • Nakano N, Matsuda S, Ichimura M, et al. PI3K/AKT signaling mediated by G proteincoupled receptors is involved in neurodegenerative Parkinson’s disease (Review). Int J Mol Med. 2017;39(2):253–260.
  • Sangawa A, Shintani M, Yamao N, et al. Phosphorylation status of Akt and caspase-9 in gastric and colorectal carcinomas. Int J Clin Exp Pathol. 2014;7(6):3312–3317.
  • Wan X, Zhu Y, Zhang L, et al. Gefitinib inhibits malignant melanoma cells through the VEGF/AKT signaling pathway. Mol Med Rep. 2018;17(5):7351–7355.
  • Li Y, Wang D, Ren H, et al. Metformin alleviates breast cancer through targeting high-mobility group AT-hook 2. Thorac Cancer. 2020;11(3):686–692.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.